Fady Kaldas Selected Research

Endothelins (Endothelin)

12/2008

Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fady Kaldas Research Topics

Disease

3	Neoplasms (Cancer) 04/2016 - 06/2011
3	Reperfusion Injury 12/2008 - 08/2002
2	Hepatocellular Carcinoma (Hepatoma) 12/2012 - 06/2011
2	Ischemia 12/2008 - 02/2006
1	End Stage Liver Disease 01/2021
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Hepatic Encephalopathy 01/2018
1	Communicable Diseases (Infectious Diseases) 04/2016
1	Anemia 09/2015
1	Hepatitis 09/2015
1	Hepatitis C 09/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2012
1	Hypoxia (Hypoxemia) 02/2006

Drug/Important Bio-Agent (IBA)

1	Tuberculin (PPD)IBA 04/2016
1	Erythropoietin FDA Link 09/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2015
1	Ribavirin (Virazole)FDA LinkGeneric 09/2015
1	SofosbuvirIBA 09/2015
1	Biomarkers (Surrogate Marker)IBA 06/2011
1	Endothelin Receptor AntagonistsIBA 12/2008
1	tezosentanIBA 12/2008
1	Endothelins (Endothelin)IBA 12/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2006
1	SelectinsIBA 08/2002
1	P-selectin ligand proteinIBA 08/2002

Therapy/Procedure

4	Liver Transplantation 01/2021 - 06/2011
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2018
1	Blood Transfusion (Blood Transfusions) 09/2015
1	Transplantation 06/2011
1	Therapeutics 06/2011